Many people like to include devices in their treatment plans because they are non-invasive and have low side-effect profiles. In this week’s episode of Heads Up, Dr. Tim Smith and Dr. Lindsay Weitzel discuss
New data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness in Episode 69 of Heads UP.
Dr. Timothy Smith and Dr. Lindsay Weitzel compare and contrast three oral gepants, an IV monoclonal antibody, two combination therapies, and an anti-inflammatory agent – all expected to be available for the treatment of